Consumer Health

In 2023, Australians suffered from an extended influenza season, with months where people were prone to sickness. Analgesics had already seen strong growth in the last few years due to widespread illness as a result of COVID-19.However, strong growth…

Analgesics continued to see solid growth in current value terms in 2023, following the easing of most COVID-19-related restrictions in September 2022. With measures such as lockdowns, mandatory mask-wearing and social distancing no longer in place,…

The briefing introduces the Cities Households Necessities Spending Index. The index ranks 1,075 cities by household expenditure on non-discretionary items, namely food, housing, and clothing and footwear. This analysis focuses on 160 major cities.…

With the ending of lockdowns, border closures, and other COVID-19-related restrictions over the course of 2022, Australia has begun to see a return to normality in 2023, with Australians settling into their new hybrid routines and lifestyles.…

The consumer health industry in New Zealand continued to witness robust growth in current value terms in 2023. The year marked a return to a semblance of normality in the country, following the reopening of borders and the lifting of COVID-19…

Australia has been impacted by an extended season of colds and flu in 2023, with many Australians becoming ill. As the lockdowns and COVID-19 restrictions were lifted, people no longer followed social distancing, and fewer Australians have been…

With an early start to the influenza season, many New Zealanders were caught off guard and succumbed to the virus throughout 2023. With a dry cough being one of the most common flu symptoms, demand for treatments to help soothe the throat was…

The report will explore the key themes transforming consumer behaviour in Asia Pacific in the world beyond the pandemic, namely Digital Living, Rethink Wellness, Sustainable Living, Make My Life Easier and Search for Experiences, and the strategies…

Dermatologicals is set to see a strong performance in 2023, with all the major categories seeing mid to high single-digit growth in retail current value terms. Antifungals (topical antifungals and vaginal antifungals) is one of the largest categories…

Topical antifungals was one of the most dynamic subcategories within dermatologicals in current value terms in 2023, continuing the trend of the previous year. Following a sluggish performance during the first three years of the review period, such…

Rising inflation in 2023 is placing downwards pressure on disposable incomes in Australia, which is having a significant impact on discretionary spending. While there is still robust interest in dietary supplements, such products are expensive, and…

Retail sales of dietary supplements in New Zealand saw stronger growth in current value terms in 2023. However, much of this was driven by increases in unit prices, due to inflation, rather than any significant upturn in demand. The country high…

Diarrhoeal remedies is set to see solid growth in Australia in 2023, with more Australians finding themselves in need of such products compared with previous years. Australians are spending more time outside the home, and are once again vulnerable to…

The increasing propensity of consumers to dine out, following the ending of COVID-19 restrictions, triggered a rise in demand for digestive remedies in New Zealand in 2023, continuing the trend that was seen during the second half of the previous…

Eye health is an ongoing concern for Australians, with this worsening for many people over the last five years. With rates of chronic eye conditions such as myopia increasing amongst consumers, there is growing demand for eye care products to help…

Eye health is a major global concern with short-sightedness (myopia) affecting people from a younger age. This is thought to be due to lifestyle factors, including reduced exposure to sunlight, and the propensity of the population to spend more time…

The briefing examines how personalised healthcare market is evolving. The report also provides insights on the countries most ready to use personalised healthcare services, and the potential impact on the pharmaceuticals and medical sectors.

This report examines inflation levels and drivers globally and in key countries. In 2023, global inflation is expected to ease from its peak in 2022, but remaining significantly above-trend. Geopolitical risks and uncertainty in the energy market are…

This report examines inflation levels and drivers globally and in key countries. Global inflation is reaching a peak, although geopolitical risks and uncertainty in the energy market remain key risks. The impact varies between countries, with…

The coronavirus (COVID-19) pandemic has triggered the most severe global recession since World War II. In Q4 2020, the end of the pandemic started as countries began administering effective vaccines among the population; however, vaccine distribution…